Axsome Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. AXSM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

188,258

Value ($000)

34,383

Weight

0.1%

2022 Q1 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	34,383	0.1%	188,258	12/31/2025
2025 Q3	11/13/2025	25,391	0.1%	209,069	9/30/2025
2025 Q2	8/7/2025	23,459	0.1%	224,721	6/30/2025
2025 Q1	5/12/2025	20,520	0.1%	175,942	3/31/2025
2024 Q4	2/10/2025	6,219	0.0%	73,497	12/31/2024
2023 Q4	2/9/2024	1,141	0.0%	14,339	12/31/2023
2022 Q1	5/12/2022	381	0.0%	9,195	3/31/2022